Nanoformulation-based medicines for the treatment of reactive oxygen species-induced diseases: A review.
Nanofabrication,
[S. l.], v. 10, 2025. DOI:
10.37819/nanofab.10.2055. DisponÃvel em:
https://www.eaapublishing.org/journals/index.php/nanofab/article/view/2055. Acesso em: 8 oct. 2025.